South Korea
· Delayed Price · Currency is KRW MedPacto Statistics
Total Valuation
MedPacto has a market cap or net worth of KRW 112.77 billion. The enterprise value is 59.23 billion.
| Market Cap | 112.77B |
| Enterprise Value | 59.23B |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MedPacto has 34.28 million shares outstanding. The number of shares has increased by 58.72% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 34.28M |
| Shares Change (YoY) | +58.72% |
| Shares Change (QoQ) | +1.15% |
| Owned by Insiders (%) | 13.36% |
| Owned by Institutions (%) | 5.30% |
| Float | 24.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.95 |
| P/TBV Ratio | 1.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.94 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.51 |
Financial Position
The company has a current ratio of 41.29, with a Debt / Equity ratio of 0.03.
| Current Ratio | 41.29 |
| Quick Ratio | 40.62 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -237.19 |
Financial Efficiency
Return on equity (ROE) is -29.88% and return on invested capital (ROIC) is -19.58%.
| Return on Equity (ROE) | -29.88% |
| Return on Assets (ROA) | -19.30% |
| Return on Invested Capital (ROIC) | -19.58% |
| Return on Capital Employed (ROCE) | -36.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.80% in the last 52 weeks. The beta is 1.12, so MedPacto's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -66.80% |
| 50-Day Moving Average | 3,290.30 |
| 200-Day Moving Average | 5,199.05 |
| Relative Strength Index (RSI) | 53.77 |
| Average Volume (20 Days) | 122,117 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.81B |
| Pretax Income | -20.14B |
| Net Income | -20.14B |
| EBITDA | -20.27B |
| EBIT | -21.81B |
| Earnings Per Share (EPS) | -598.04 |
Balance Sheet
The company has 55.48 billion in cash and 1.94 billion in debt, giving a net cash position of 53.54 billion or 1,562.00 per share.
| Cash & Cash Equivalents | 55.48B |
| Total Debt | 1.94B |
| Net Cash | 53.54B |
| Net Cash Per Share | 1,562.00 |
| Equity (Book Value) | 57.74B |
| Book Value Per Share | 1,684.70 |
| Working Capital | 55.41B |
Cash Flow
In the last 12 months, operating cash flow was -16.56 billion and capital expenditures -313.89 million, giving a free cash flow of -16.87 billion.
| Operating Cash Flow | -16.56B |
| Capital Expenditures | -313.89M |
| Free Cash Flow | -16.87B |
| FCF Per Share | -492.28 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedPacto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.72% |
| Shareholder Yield | -58.72% |
| Earnings Yield | -17.86% |
| FCF Yield | -14.96% |
Stock Splits
The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.
| Last Split Date | May 13, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |